Edition:
India

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

7,091.00ZAc
22 Aug 2019
Change (% chg)

139.00 (+2.00%)
Prev Close
6,952.00
Open
6,900.00
Day's High
7,435.00
Day's Low
6,765.00
Volume
2,173,154
Avg. Vol
1,838,217
52-wk High
29,800.00
52-wk Low
6,407.00

Select another date:

Wed, Aug 14 2019

Photo

South Africa's Aspen to pay 8 million pounds to NHS after UK probe

British authorities said on Wednesday South Africa's Aspen Pharmacare Holdings Ltd has agreed to pay the National Health Service (NHS) 8 million pounds ($9.65 million) to resolve concerns related to overpayment for a treatment.

UPDATE 1-South Africa's Aspen to pay 8 mln pounds to NHS after UK probe

Aug 14 British authorities said on Wednesday South Africa's Aspen Pharmacare Holdings Ltd has agreed to pay the National Health Service (NHS) 8 million pounds ($9.65 million) to resolve concerns related to overpayment for a treatment.

South Africa's Aspen to pay 8 mln pounds to NHS after UK probe

Aug 14 British authorities said on Wednesday South Africa's Aspen Pharmacare Holdings Ltd has agreed to pay the National Health Service (NHS) 8 million pounds ($9.65 million) to resolve competition concerns related to a company's treatment.

South African drugmaker Aspen terminates talks with potential European partner

JOHANNESBURG, July 5 South African drugmaker Aspen Pharmacare said on Friday it had terminated talks with a potential partner in Europe, after announcing in March a strategic review of its European and domestic commercial pharmaceuticals businesses.

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

UPDATE 1-South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy Aspen's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

UPDATE 1-South Africa's rand recovers after U.S. jobs data, stocks slide on Aspen

JOHANNESBURG, March 8 South Africa's rand firmed on Friday, recovering from a nine-week low after sluggish U.S. employment data pushed the dollar lower and saw demand for emerging markets return.

Select another date: